Efficacy and safety study of tafenoquine (TQ) co-administered with dihydroartemisinin-piperaquine (DHA-PQP) for the radical cure of Plasmodium vivax (P. vivax) malaria

Trial Identifier:	200894
Sponsor:	GlaxoSmithKline
Collaborator:	Medicines for Malaria Venture
Start Date:	April 2018
Primary Completion Date:	August 2019
Study Completion Date:	August 2019
Condition:	Parasite Infections

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Indonesia	Jakarta, Indonesia, 10430

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.